Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nanovibronix Inc (NQ: NAOV )

0.7451 -0.0549 (-6.86%)
Streaming Delayed Price Updated: 3:56 PM EDT, Apr 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,793
Open 0.7452
Bid (Size) 0.7744 (1)
Ask (Size) 0.8000 (19)
Prev. Close 0.8000
Today's Range 0.7451 - 0.8000
52wk Range 0.7000 - 4.230
Shares Outstanding 2,784,354
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023
NanoVibronix just reported results for the fourth quarter of 2023. 
Via InvestorPlace
NanoVibronix Issues Letter to Stockholders
From NanoVibronix, Inc.
Via Business Wire

Performance

YTD
-35.21%
-35.21%
1 Month
-15.33%
-15.33%
3 Month
-12.34%
-12.34%
6 Month
-24.74%
-24.74%
1 Year
-76.93%
-76.93%

More News

Read More
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
NanoVibronix Featured in Your Bladder Health Magazine
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Regains Nasdaq Compliance
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
NanoVibronix Issues Letter to Shareholders
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1
From NanoVibronix, Inc.
Via Business Wire
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
From NanoVibronix, Inc.
Via Business Wire
BioMedNewsBreaks – IBN’s BioMedWire Highlights NanoVibronix Inc.’s (NASDAQ: NAOV) $5M Private Placement
Via Investor Brand Network
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stocks Higher Midday, Look To Extend Positive Week
Via Talk Markets
Why REX American Resources Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Gold Moves Higher; Outlook Therapeutics Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
NanoVibronix Inc. (NASDAQ: NAOV) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
Dear ACHR Stock Fans, Mark Your Calendars for Sept. 12
Via InvestorPlace
Why Is NanoVibronix (NAOV) Up 153% Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.